Thomas Freeburg named CFO at Niki BioSolutions

Niki BioSolutions (NASDAQ:NIKI) announced its subsidiary DiamiR Biosciences received approval from New York State to expand specimen types for its APOE Genotyping test, including dried blood spots, plasma, and urine. The test identifies genetic variants linked to Alzheimer's and other conditions. The company stated this may enable at-home sample collection and ambient-temperature shipping.

Niki BioSolutions (NASDAQ: NIKI) announced that its subsidiary DiamiR Biosciences received NYSDOH CLEP approval to expand its APOE Genotyping test to include urine, plasma, and dried blood spots. The test, which identifies genetic variants linked to Alzheimer’s risk, was previously approved for blood, buccal swab, saliva, and tissue. The expansion allows for more accessible testing, including at-home or point-of-care sample collection, and supports integrated genetic and biomarker workflows.

A Nigerian court approved a settlement in a dispute involving Shell, Aiteo, and lenders over a $2B financing arrangement related to Shell's 2015 sale of Nigerian oil assets. Shell provided $512M in vendor financing to Aiteo, leading to years of litigation. The settlement's terms are not fully disclosed, but it resolves disputes over the financial arrangements.

Tesla was found liable for fraud and negligent misrepresentation in a Solar Roof lawsuit. The judge ruled after Tesla missed deadlines for evidence production. The case involves an uncompleted project and damages sought by the homeowner. Tesla has admitted to breaching the contract and acting negligently, but disputes the fraud and misrepresentation claims. The trial will focus on compensatory and punitive damages.

The U.S. Air Force plans to invest $1.057 billion in a new complex at Nellis Air Force Base to test and maintain Boeing's F-47 stealth fighter, a sixth-generation aircraft exceeding 2,400 km/h. The facility will evaluate combat capabilities, train crews, and integrate unmanned drones. The F-47 will replace the F-22 Raptor, with speeds over Mach 2 and a 1,600 km combat radius, featuring stealth and advanced sensors.

Alstom signed a €460M contract with the Royal Commission for Riyadh City to supply driverless metro trains for Riyadh's Lines 3, 4, and 6, expanding the existing fleet. The deal, valued at $585.5M including VAT, will be recognized in Q2 of Alstom's 2026/27 financial year. The new trains aim to increase capacity and service frequency, according to Alstom.